key: cord-0924234-0vnpodgu
authors: Eaaswarkhanth, Muthukrishnan; Madhoun, Ashraf Al; Al-Mulla, Fahd
title: Could the D614 G substitution in the SARS-CoV-2 spike (S) protein be associated with higher COVID-19 mortality?
date: 2020-05-26
journal: Int J Infect Dis
DOI: 10.1016/j.ijid.2020.05.071
sha: dc897a1e1147d95793029b181865f3fc8876e175
doc_id: 924234
cord_uid: 0vnpodgu

Increasing number of deaths due to COVID-19 pandemic has raised serious global concerns. Higher testing capacity and ample intensive care availability could explain lower mortality in some countries compared to others. Nevertheless, it is also plausible that the SARS-CoV-2 mutations giving rise to different phylogenetic clades are responsible for the obvious death disparities around the world. Current research literature linking the genetic make-up of SARS-CoV-2 with fatality is lacking. Here, we suggest that this disparity in fatality rates may be attributed to SARS-CoV-2 evolving mutations and urge the international community to begin addressing the phylogenetic clade classification of SARS-CoV-2 in relation to clinical outcomes.

mutations giving rise to different phylogenetic clades are responsible for the obvious death disparities around the world. Current research literature linking the genetic make-up of SARS-CoV-2 with fatality is lacking. Here, we suggest that this disparity in fatality rates may be attributed to SARS-CoV-2 evolving mutations and urge the international community to begin addressing the phylogenetic clade classification of SARS-CoV-2 in relation to clinical outcomes.

The rapid spread of novel SARS-CoV-2 across the globe has become a major threat to the humankind (Wang et al., 2020) . Since the emergence of SARS-CoV-2, the emphasis on combatting the COVID-19 pandemic focused on social distancing and lockdown of cities in order to avoid medical care bottlenecks and to spread-out critical care over time. However, the escalating death toll in some countries when compared with others is alarming (World Health Organization 2020). Several factors including but not limited to, age and comorbid health conditions have been significantly linked to higher fatalities, especially in Italy (Onder et al., 2020) . Such differences in fatality rates could be linked to genetic variations in SARS-CoV-2, but the literature pertaining to this is lacking.

Currently, complete SARS-CoV-2 sequences using NGS technology are being deposited at GISAID (Shu and McCauley 2017) . These sequences are being extensively scrutinized to understand their transmission, evolutionary and genetic relationships through phylogeny (Hadfield et al., 2018) . However, it is unclear whether SARS-CoV-2 genetic mutations influence its transmissibility and/or virulence, which may account for the higher fatalities in some countries. Here, we utilized the phylogenetic tree of 4,246 SARS-CoV-2 genomes obtained from GISAID (Shu and McCauley 2017) and predict a possible link between higher fatalities and J o u r n a l P r e -p r o o f SARS-CoV-2 codon 614 in Spike protein (S), which replaces Aspartic acid (D) with Glycine (G) at this site. The SARS-CoV-2 genomes with S-D614G variant has been classified under a larger phylogenetic clade G constituting most strains from Europe (Fig.1A ) (Shu and McCauley 2017; Hadfield et al., 2018) . Notably, mutations in S protein likely induce conformational modifications that alters antigenicity (Phan 2020) , plausibly by mimicking the open status and facilitates the exposure of the cleavage domain to proteases, FURIN or TMPRSS2, and could be sufficient to speed up the cleavage (Fig. 2) .

Strikingly, we observed that the variant S-D614G distinguishes the SARS-CoV-2 strains ( Fig.1A ) that may have caused fatal infections in European populations (Fig.1B) . For example, the substantial number of strains with S-D614G variant are from the countries (Belgium, Spain, Italy, France, Netherlands and Switzerland) that top the death toll (Fig.1B) (https://www.worldometers.info/coronavirus/; last accessed May 2, 2020); while Germany and Kuwait with lower death toll constitute most strains with the wild-type 614D at S (Fig.1B) . It is also important to note that this scenario in Germany and other European countries remain uncertain as the number of cases are increasing every day. Therefore, continuous assessment and follow-up will be crucial to contain the virus.

Overall, our observation speculates that the S-D614G strains may be virulent increasing the severity in the infected individuals, especially in Europe where this mutation is prominent.

While our evidence is circumstantial, examining the amino acid 614 at S protein site (or other mutations) in patients with mild versus critically ill patients may be an asset in our arsenal against COVID-19. In the absence of any experimental studies, our interpretation with limited data will be certainly helpful for the researchers at this time. 

COVID-19 Coronavirus Pandemic: Confirmed Cases and Deaths by Country

Nextstrain: real-time tracking of pathogen evolution

Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy

Genetic diversity and evolution of SARS-CoV-2

Global initiative on sharing all influenza data -from vision to reality

A novel coronavirus outbreak of global health concern

World Health Organization: Coronavirus disease (COVID-2019) situation reports

We gratefully acknowledge the authors, originating and submitting laboratories of the sequence data from GISAID on which this research is based. This study was supported by the Kuwait Foundation for the Advancement of Sciences.J o u r n a l P r e -p r o o f